Stock listing

GNLX Stock Price, News, Filings & Events — Genelux Corporation

Selected listing: GNLX · BOATS · USD · US

This page tracks Genelux Corporation's GNLX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GNLX:BOATS. GNLX:BOATS is the stock-level entry point for investors researching Genelux Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genelux Corporation, trading under the ticker GNLX, is a public company based in the United States with a market capitalization of approximately $129.6 million. The company focuses on developing innovative therapies for cancer treatment. Genelux aims to advance its proprietary technologies to improve patient outcomes in oncology.

GNLX:BOATSUSDUSUpdated September 11, 2026
Genelux Corporation logo
Ticker
GNLX:BOATS
Asset type
Stock
Market cap
$112.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Genelux Corporation GNLX:BOATS stock context

This page tracks Genelux Corporation's GNLX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GNLX:BOATS. GNLX:BOATS is the stock-level entry point for investors researching Genelux Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genelux Corporation, trading under the ticker GNLX, is a public company based in the United States with a market capitalization of approximately $129.6 million. The company focuses on developing innovative therapies for cancer treatment. Genelux aims to advance its proprietary technologies to improve patient outcomes in oncology.

Latest news from Genelux Corporation

All Genelux Corporation news →

Research Genelux Corporation

Alternate listings